Skip to content
OpenCapital
Get started

Merit Medical Systems MMSI EBITDA

EBITDA at other companies

TFX
TeleflexTFX
$73.93M-35.4%
Abbott logo
AbbottABT
——
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
——
Johnson & Johnson logo
Johnson & JohnsonJNJ
——
Stryker logo
StrykerSYK
——
Boston Scientific logo
Boston ScientificBSX
——

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Return on equity9.1%0.0pp
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Calculated from Merit Medical Systems’s reported figures.

$44.2Mebit+
$30.5MDepreciation Depletion & Amortization
=$74.65M

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's EBITDA?
Merit Medical Systems (MMSI) reported EBITDA of $74.65M in Q1 2026.
How has Merit Medical Systems's EBITDA changed year-over-year?
Merit Medical Systems's EBITDA increased by 6.2% year-over-year, from $70.33M to $74.65M.
What is the long-term trend for Merit Medical Systems's EBITDA?
Over 4 years (2021 to 2025), Merit Medical Systems's EBITDA has grown at a 20.7% compound annual growth rate (CAGR), from $144.98M to $307.89M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.